Carboplatin Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Carboplatin Injection (injection) from Teva Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on 04/28/2023. Reported reason: Other
Shortage Details
- Status
- Current
- Company
- Teva Pharmaceuticals USA, Inc.
- Package NDC
- 0703-4248-01
- Dosage Form
- Injection
- Presentation
- Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4248-01)
- Initial Posting
- 04/28/2023
- Revised Date
Reason
Other